Literature DB >> 19373464

Atherosclerosis is an inflammatory disease.

Fabrizio Montecucco1, François Mach.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19373464     DOI： 10.1007/s00281-009-0146-7

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN： 1863-2297            Impact factor:   9.623


× No keyword cloud information.
  17 in total

1.  Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice.

Authors:  Sabine Steffens; Niels R Veillard; Claire Arnaud; Graziano Pelli; Fabienne Burger; Christian Staub; Meliha Karsak; Andreas Zimmer; Jean-Louis Frossard; François Mach
Journal:  Nature       Date:  2005-04-07       Impact factor: 49.962

Review 2.  Sleep apnea.

Authors:  A Masood; B Phillips
Journal:  Curr Opin Pulm Med       Date:  2000-11       Impact factor: 3.155

Review 3.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

Review 4.  Leukocyte recruitment in atherosclerosis: potential targets for therapeutic approaches?

Authors:  V Braunersreuther; F Mach
Journal:  Cell Mol Life Sci       Date:  2006-09       Impact factor: 9.261

Review 5.  The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models.

Authors:  Christian Weber; Alma Zernecke; Peter Libby
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

Review 6.  CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant.

Authors:  A J Scheen
Journal:  J Neuroendocrinol       Date:  2008-05       Impact factor: 3.627

7.  CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.

Authors:  Fabrizio Montecucco; Fabienne Burger; François Mach; Sabine Steffens
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-04       Impact factor: 4.733

Review 8.  Connexins in vascular physiology and pathology.

Authors:  Anne C Brisset; Brant E Isakson; Brenda R Kwak
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

9.  Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.

Authors:  Luc Van Gaal; Xavier Pi-Sunyer; Jean-Pierre Després; Christine McCarthy; André Scheen
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

10.  CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.

Authors:  Fabrizio Montecucco; Sébastien Lenglet; Vincent Braunersreuther; Fabienne Burger; Graziano Pelli; Maria Bertolotto; François Mach; Sabine Steffens
Journal:  J Mol Cell Cardiol       Date:  2009-01-07       Impact factor: 5.000
View more
  9 in total

1.  Establishment of nasal tolerance to heat shock protein-60 alleviates atherosclerosis by inducing TGF-β-dependent regulatory T cells.

Authors:  Haiyu Li; Yanping Ding; Guiwen Yi; Qiutang Zeng; Wenkai Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-01-27

2.  Relationship between high-sensitivity C-reactive protein and subclinical carotid atherosclerosis stratified by glucose metabolic status in Chinese adults.

Authors:  Haiyan Su; Yinghua Pei; Chunling Tian; Qing Zhang; Li Liu; Ge Meng; Zhanxin Yao; Hongmei Wu; Yang Xia; Xue Bao; Yeqing Gu; Shaomei Sun; Xing Wang; Ming Zhou; Qiyu Jia; Kun Song; Zhong Sun; Kaijun Niu
Journal:  Clin Cardiol       Date:  2018-12-10       Impact factor: 2.882

3.  Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status.

Authors:  Martha Savaria Morris; Lydia Sakakeeny; Paul F Jacques; Mary Frances Picciano; Jacob Selhub
Journal:  J Nutr       Date:  2009-11-11       Impact factor: 4.798

4.  Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids.

Authors:  Piotr Ruchala; Mohamad Navab; Chun-Ling Jung; Susan Hama-Levy; Ewa D Micewicz; Hai Luong; Jonathan E Reyles; Shantanu Sharma; Alan J Waring; Alan M Fogelman; Robert I Lehrer
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

5.  Protocatechuic aldehyde inhibits TNF-α-induced fibronectin expression in human umbilical vein endothelial cells via a c-Jun N-terminal kinase dependent pathway.

Authors:  Yue-Feng Tong; Yong Liu; Zhi-Xing Hu; Zhe-Cheng Li; Agula A
Journal:  Exp Ther Med       Date:  2015-11-25       Impact factor: 2.447

6.  Atherosclerosis and rheumatoid arthritis: more than a simple association.

Authors:  Lorenzo Cavagna; Nicola Boffini; Giovanni Cagnotto; Flora Inverardi; Vittorio Grosso; Roberto Caporali
Journal:  Mediators Inflamm       Date:  2012-09-13       Impact factor: 4.711

Review 7.  CD154: the atherosclerotic risk factor in rheumatoid arthritis?

Authors:  Ghada S Hassan; Daniel Yacoub; Nada Alaaeddine; Amal Nadiri; Yahye Merhi; Walid Mourad
Journal:  Arthritis Res Ther       Date:  2013-02-22       Impact factor: 5.156

8.  Effects of Urinary Kallidinogenase on NIHSS score, mRS score, and fasting glucose levels in acute ischemic stroke patients with abnormal glucose metabolism: A prospective cohort study.

Authors:  Lei Chen; Lianxia Geng; Junmin Chen; Yan Yan; Lan Yang; Jing Zhao; Qian Sun; Junna He; Lin Bai; Xiaopeng Wang
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

9.  The Challenges of Arterial Hypertension.

Authors:  Gian Paolo Rossi
Journal:  Front Cardiovasc Med       Date:  2015-02-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.